✦ LIBER ✦

Rituximab therapy increased post-transplant cytomegalovirus complications in Non-Hodgkin’s lymphoma patients receiving autologous hematopoietic stem cell transplantation

✍ Scribed by Ming-Yang Lee; Tzeon-Jye Chiou; Liang-Tsai Hsiao; Muh-Hwa Yang; Pang-Chan Lin; Say-Bee Poh; Chueh-Chuan Yen; Jin-Hwang Liu; Hao-Wei Teng; Ta-Chung Chao; Wei-Shu Wang; Po-Min Chen

Publisher: Springer
Year: 2007
Tongue: English
Weight: 111 KB
Volume: 87
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-007-0397-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab long-term maintenance therapy

Rituximab long-term maintenance therapy after autologous stem cell transplantation in patients with B-cell non-Hodgkin’s lymphoma

✍ Frank Neumann; Stefani Harmsen; Simona Martin; Ralf Kronenwett; Mustafa Kondakci 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 96 KB

Post-autologous stem cell transplantatio

Post-autologous stem cell transplantation administration of rituximab improves the outcome of patients with aggressive B cell non-Hodgkin’s lymphoma

✍ Panagiotis Tsirigotis; Liliane Dray; Igor B. Resnick; Aliza Ackerstein; Benjamin 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 187 KB

Therapeutic results in patients with rel

Therapeutic results in patients with relapsed diffuse large B cell Non-Hodgkin's lymphoma achieving complete response only after autologous stem cell transplantation

✍ Felicetto Ferrara; Assunta Viola; Carolina Copia; Ettore Mariano Schiavone; Mari 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

## Abstract Forty patients with relapsed diffuse large B cell lymphoma (DLBCL) autografted in partial response (PR) (__n__ = 23) or in refractory relapse (RR) (__n__ = 17) achieved complete remission (CR) after autologous stem cell transplantation (ASCT). Salvage treatment consisted of ifosphamide,

BEAC or BEAM high-dose chemotherapy foll

BEAC or BEAM high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin’s lymphoma patients: comparative analysis of efficacy and toxicity

✍ Jae-Cheol Jo; Byung Wook Kang; Geundoo Jang; Sun Jin Sym; Sung Sook Lee; Ja Eun 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 144 KB

A long-lasting third complete remission

A long-lasting third complete remission after second autologous transplant followed by maintenance treatment with rituximab in a patient with diffuse large cell non-Hodgkin's lymphoma

✍ Selmin Ataergin; Fikret Arpaci; Murat Beyzadeoglu; Mukerrem Safali; Ahmet Ozet 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB 👁 1 views